Online edition of India's National Newspaper
Wednesday, Feb 21, 2007
ePaper
Google



Business
News: ePaper | Front Page | National | Tamil Nadu | Andhra Pradesh | Karnataka | Kerala | New Delhi | Other States | International | Opinion | Business | Sport | Miscellaneous | Engagements |
Advts:
Classifieds | Jobs | Obituary |



Business - Briefly Printer Friendly Page   Send this Article to a Friend

Bentley gets DCGI nod for Nasulin Phase II trial

BANGALORE: Biocon announced on Tuesday that its licensing partner, Bentley Pharmaceuticals Inc., a specialty pharmaceutical company, has received approval from the Drug Controller General of India (DCGI) to proceed with Phase II clinical evaluation of `Nasulin', an intranasal insulin product, in Type II diabetic patients. As per the licensing agreement, Biocon is responsible for developing and marketing Nasulin in India and select territories.

Printer friendly page  
Send this article to Friends by E-Mail



Business

News: ePaper | Front Page | National | Tamil Nadu | Andhra Pradesh | Karnataka | Kerala | New Delhi | Other States | International | Opinion | Business | Sport | Miscellaneous | Engagements |
Advts:
Classifieds | Jobs | Obituary | Updates: Breaking News |


News Update


The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | The Hindu ePaper | Business Line | Business Line ePaper | Sportstar | Frontline | Publications | eBooks | Images | Home |

Copyright 2007, The Hindu. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu